$FEMY
New to this type of trading/investing.....trying to learn, especially the lingo
Recent FEMY News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/07/2024 08:01:11 PM
- Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative • GlobeNewswire Inc. • 05/17/2024 12:30:00 PM
- Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council • GlobeNewswire Inc. • 05/16/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 12:40:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:35:22 PM
- Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update • GlobeNewswire Inc. • 05/09/2024 12:30:00 PM
- Femasys Expands Commercial Management Team with Addition of Experienced New Hires • GlobeNewswire Inc. • 05/07/2024 12:30:00 PM
- Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives • GlobeNewswire Inc. • 04/18/2024 12:30:00 PM
- Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update • GlobeNewswire Inc. • 03/28/2024 08:05:00 PM
- Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape • GlobeNewswire Inc. • 03/21/2024 01:00:00 PM
- Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility • GlobeNewswire Inc. • 03/20/2024 12:15:00 PM
- Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024 • GlobeNewswire Inc. • 03/13/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 02:09:27 PM
- Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution • GlobeNewswire Inc. • 03/06/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 02:16:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 02:47:58 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 02:44:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 01:47:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:43:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:42:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:42:56 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/11/2023 05:15:27 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/08/2023 02:28:26 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/30/2023 10:17:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:05:50 PM
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM